University of Maryland has identified proteolysis targeting chimeras (PROTACs) acting as apoptosis regulator Bcl-2, Bcl-2-like protein 1 (BCL2L1) and induced myeloid leukemia cell differentiation protein Mcl-1 degradation inducers.